Release Date: 22/10/18 10:00 Summary: Caula Vanadium-Graphite Scoping Study Exceptional Economics Price Sensitive: Yes Download Document 3.09MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%